Publicaciones en colaboración con investigadores/as de Free University of Berlin (11)

2023

  1. Impact of body composition in advanced hepatocellular carcinoma: A subanalysis of the SORAMIC trial

    HEPATOLOGY COMMUNICATIONS, Vol. 7, Núm. 6

  2. Robotic versus laparoscopic liver resection for huge (≥10 cm) liver tumors: an international multicenter propensity-score matched cohort study of 799 cases

    HEPATOBILIARY SURGERY AND NUTRITION, Vol. 12, Núm. 2, pp. 205-216

2022

  1. An international multicenter propensity-score matched and coarsened-exact matched analysis comparing robotic versus laparoscopic partial liver resections of the anterolateral segments

    Journal of Hepato-Biliary-Pancreatic Sciences, Vol. 29, Núm. 8, pp. 843-854

2021

  1. Autoimmune diseases are linked to type IIb autoimmune chronic spontaneous urticaria

    Allergy, Asthma and Immunology Research, Vol. 13, Núm. 3

  2. ESGO/ESTRO/ESP Guidelines for the management of patients with endometrial carcinoma

    Virchows Archiv, Vol. 478, Núm. 2, pp. 153-190

  3. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

2019

  1. LPS-neutralizing peptides reduce outer membrane vesicle-induced inflammatory responses

    Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids, Vol. 1864, Núm. 10, pp. 1503-1513

  2. Synthetic anti-lipopolysaccharide peptides (SALPs) as effective inhibitors of pathogen-associated molecular patterns (PAMPs)

    Advances in Experimental Medicine and Biology (Springer New York LLC), pp. 111-129

  3. Ultrasound and clinical preoperative characteristics for discrimination between ovarian metastatic colorectal cancer and primary ovarian cancer: A case-control study

    Diagnostics, Vol. 9, Núm. 4

2018

  1. Antimicrobial endotoxin-neutralizing peptides promote keratinocyte migration via P2X7 receptor activation and accelerate wound healing in vivo

    British Journal of Pharmacology, Vol. 175, Núm. 17, pp. 3581-3593

  2. Inhibition of lipopolysaccharide- and lipoprotein-induced inflammation by antitoxin peptide Pep19-2.5

    Frontiers in Immunology